|
CLINICAL TRIALS Trial No ClinicalTrials.gov ID |
Phase | Coordinator | |
|---|---|---|---|
|
A Randomized Phase II Study of Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Positive Advanced Gastroesophageal Adenocarcinoma
CCTG GA4 NCT06043427  Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL |
Chantal Gosselin 514-890-8000 poste 24892 |
Groupe d'étude en oncologie du Québec